ArthroCare (ARTC) Reports In-Line Q2 EPS of 34c
Tweet
Share
E-mailGet Alerts ARTC Hot Sheet
Price: $9.97 --0%
Financial Fact:
Amortization of intangible assets: 524K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Amortization of intangible assets: 524K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
ArthroCare (NASDAQ: ARTC) reported Q2 EPS of $0.34, in-line with the analyst estimate of $0.34. Revenue for the quarter came in at $91.3 million versus the consensus estimate of $92.32 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
